Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 2/2018

27.02.2018 | Case Report

Fatal intoxication with antidepressants: a case with many culprits

verfasst von: Antonis Goulas, Nikolaos Raikos, Diamantis Krokos, Orthodoxia Mastrogianni, Amvrosios Orphanidis, Konstantinos Zisopoulos, Androniki Tsepa

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Serotonin-specific reuptake inhibitors (SSRIs) are generally considered safe drugs but fatal adverse effects do sometimes occur, often as a consequence of interactions with other serotonin active drugs. Polypharmacy is usually a problem that the elderly encounter, but it can also have dire consequences for young people, especially when an underlying heart condition is present. Thus, failure to diagnose heart disease and the use of contraindicated medications can be a lethal combination, irrespective of age. Here we present a case of a young adult suffering from bipolar disorder who used a combination of two SSRIs (citalopram and fluoxetine) and a monoamine oxidase inhibitor (MAO; moclobemide) with tragic consequences. The deceased also suffered from undiagnosed hypertrophic cardiomyopathy and was carrier of a genotype that may have predisposed him to increased sensitivity to SSRIs. The apparent difficulty in establishing the manner of death in this case is also discussed.
Literatur
1.
Zurück zum Zitat Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci. 2000;25:241–54.PubMedPubMedCentral Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci. 2000;25:241–54.PubMedPubMedCentral
3.
Zurück zum Zitat Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32:571–605.CrossRefPubMed Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32:571–605.CrossRefPubMed
4.
Zurück zum Zitat Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125:803–15.CrossRefPubMed Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125:803–15.CrossRefPubMed
5.
Zurück zum Zitat Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2011;7:162–84.CrossRefPubMed Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2011;7:162–84.CrossRefPubMed
7.
Zurück zum Zitat Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016;26:411–9.CrossRefPubMed Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016;26:411–9.CrossRefPubMed
8.
Zurück zum Zitat Gillman K. Moclobemide and the risk of serotonin toxicity (or serotonin syndrome). CNS Drug Rev. 2004;10:83–5.CrossRefPubMed Gillman K. Moclobemide and the risk of serotonin toxicity (or serotonin syndrome). CNS Drug Rev. 2004;10:83–5.CrossRefPubMed
9.
Zurück zum Zitat Dams R, Benijts TH, Lambert WE, Van Bocxlaer JF, Van Varenbergh D, Van Peteghem C, et al. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. J Anal Toxicol. 2001;25:147–51.CrossRefPubMed Dams R, Benijts TH, Lambert WE, Van Bocxlaer JF, Van Varenbergh D, Van Peteghem C, et al. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. J Anal Toxicol. 2001;25:147–51.CrossRefPubMed
10.
Zurück zum Zitat Wu ML, Deng JF. Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose. Chang Gung Med J. 2011;34:644–9.PubMed Wu ML, Deng JF. Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose. Chang Gung Med J. 2011;34:644–9.PubMed
11.
Zurück zum Zitat Mastrogianni O, Gbandi E, Orphanidis A, Raikos N, Goutziomitrou E, Kolibianakis EM, et al. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug Metab Pharmacokinet. 2014;29:215–8.CrossRefPubMed Mastrogianni O, Gbandi E, Orphanidis A, Raikos N, Goutziomitrou E, Kolibianakis EM, et al. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug Metab Pharmacokinet. 2014;29:215–8.CrossRefPubMed
12.
Zurück zum Zitat Papazisis G, Goulas A, Sarrigiannidis A, Bargiota S, Antoniadis D, Raikos N, et al. ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting. Hum Psychopharmacol. 2018; https://doi.org/10.1002/hup.2644. Papazisis G, Goulas A, Sarrigiannidis A, Bargiota S, Antoniadis D, Raikos N, et al. ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting. Hum Psychopharmacol. 2018; https://​doi.​org/​10.​1002/​hup.​2644.
13.
Zurück zum Zitat Launiainen T, Ojanperä I. Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal. 2014;6:308–16.CrossRefPubMed Launiainen T, Ojanperä I. Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal. 2014;6:308–16.CrossRefPubMed
14.
Zurück zum Zitat Winek CL, Wahba WW, Winek CL Jr, Balzer TW. Drug and chemical blood-level data 2001. Forensic Sci Int 2001;122:107–123. Winek CL, Wahba WW, Winek CL Jr, Balzer TW. Drug and chemical blood-level data 2001. Forensic Sci Int 2001;122:107–123.
15.
Zurück zum Zitat Musshoff F, Padosch S, Steinborn S, Madea B. Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int. 2004;142:161–210.CrossRefPubMed Musshoff F, Padosch S, Steinborn S, Madea B. Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int. 2004;142:161–210.CrossRefPubMed
16.
Zurück zum Zitat Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.CrossRefPubMedPubMedCentral Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hooten WM, Hartman WR, Black JL 3rd, Laures HJ, Walker DL. Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain. BMC Med Genet 2013;14:78. Hooten WM, Hartman WR, Black JL 3rd, Laures HJ, Walker DL. Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain. BMC Med Genet 2013;14:78.
18.
Zurück zum Zitat Ojanperä I, Kriikku P, Vuori E. Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med. 2016;130:1209–16.CrossRefPubMed Ojanperä I, Kriikku P, Vuori E. Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med. 2016;130:1209–16.CrossRefPubMed
19.
Zurück zum Zitat Fu K, Konrad RJ, Hardy RW, Brissie RM, Robinson CA. An unusual multiple drug intoxication case involving citalopram. J Anal Toxicol. 2000;24:648–50.CrossRefPubMed Fu K, Konrad RJ, Hardy RW, Brissie RM, Robinson CA. An unusual multiple drug intoxication case involving citalopram. J Anal Toxicol. 2000;24:648–50.CrossRefPubMed
20.
21.
Zurück zum Zitat Koski A, Ojanperä I, Vuori E. Interaction of alcohol and drugs in fatal poisonings. Hum Exp Toxicol. 2003;22:281–7.CrossRefPubMed Koski A, Ojanperä I, Vuori E. Interaction of alcohol and drugs in fatal poisonings. Hum Exp Toxicol. 2003;22:281–7.CrossRefPubMed
22.
Zurück zum Zitat Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–60.PubMed Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–60.PubMed
23.
Zurück zum Zitat Zhu J, Klein-Fedyshin M, Stevenson JM. Serotonin transporter gene polymorphisms and selective serotonin reuptake inhibitor tolerability: review of pharmacogenetic evidence. Pharmacotherapy. 2017;37:1089–104.CrossRefPubMed Zhu J, Klein-Fedyshin M, Stevenson JM. Serotonin transporter gene polymorphisms and selective serotonin reuptake inhibitor tolerability: review of pharmacogenetic evidence. Pharmacotherapy. 2017;37:1089–104.CrossRefPubMed
24.
Zurück zum Zitat Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, et al. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci. 2011;32:507–9.CrossRefPubMed Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, et al. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci. 2011;32:507–9.CrossRefPubMed
25.
Zurück zum Zitat Unterecker S, Warrings B, Deckert J, Pfuhlmann B. Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report. Pharmacopsychiatry. 2012;45:30–4.CrossRefPubMed Unterecker S, Warrings B, Deckert J, Pfuhlmann B. Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report. Pharmacopsychiatry. 2012;45:30–4.CrossRefPubMed
26.
Zurück zum Zitat Kronenberg S, Apter A, Brent D, Schirman S, Melhem N, Pick N, et al. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol. 2007;17:741–50.CrossRefPubMed Kronenberg S, Apter A, Brent D, Schirman S, Melhem N, Pick N, et al. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol. 2007;17:741–50.CrossRefPubMed
27.
Zurück zum Zitat Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–9.CrossRefPubMed Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–9.CrossRefPubMed
28.
Zurück zum Zitat Cao J, Hudziak JJ, Li D. Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder. Neuropsychopharmacology. 2013;38:1737–47.CrossRefPubMedPubMedCentral Cao J, Hudziak JJ, Li D. Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder. Neuropsychopharmacology. 2013;38:1737–47.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Andre K, Kampman O, Illi A, Viikki M, Setälä-Soikkeli E, Mononen N, et al. SERT and NET polymorphisms, temperament and antidepressant response. Nord J Psychiatry. 2015;69:531–8.CrossRefPubMed Andre K, Kampman O, Illi A, Viikki M, Setälä-Soikkeli E, Mononen N, et al. SERT and NET polymorphisms, temperament and antidepressant response. Nord J Psychiatry. 2015;69:531–8.CrossRefPubMed
30.
Zurück zum Zitat Landrø NI. Towards personalized treatment of depression: a candidate gene approach. Scand J Psychol. 2014;55:219–24.CrossRefPubMed Landrø NI. Towards personalized treatment of depression: a candidate gene approach. Scand J Psychol. 2014;55:219–24.CrossRefPubMed
Metadaten
Titel
Fatal intoxication with antidepressants: a case with many culprits
verfasst von
Antonis Goulas
Nikolaos Raikos
Diamantis Krokos
Orthodoxia Mastrogianni
Amvrosios Orphanidis
Konstantinos Zisopoulos
Androniki Tsepa
Publikationsdatum
27.02.2018
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 2/2018
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-018-9960-3

Weitere Artikel der Ausgabe 2/2018

Forensic Science, Medicine and Pathology 2/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie